OBIO peer analysis
Orchestra BioMed (OBIO) against its competitors: price, today's move, 1-year return and market value side by side.
OBIO and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AVTX Avalo Therapeutics | $7.75 | 0.65% | -49.77% | $448.13M |
| CRBU Caribou Biosciences | $0.36 | -4.55% | -83.94% | $39.21M |
| ENTA Enanta Pharmaceuticals | $10.97 | -2.05% | -8.05% | $319.51M |
| EPRX Eupraxia | $8.17 | 4.61% | 23.79% | $549.37M |
| IVA Inventiva | $3.68 | -5.15% | -9.14% | $191.29M |
| IVVD Invivyd | $0.58 | 2.89% | -67.02% | $172.05M |
| PRLD Prelude Therapeutics | $3.45 | -1.99% | 134.69% | $275.32M |
| PYXS Pyxis Oncology | $1.58 | 0.00% | -63.84% | $100.10M |
| TARA Protara Therapeutics | $2.53 | 3.69% | -52.26% | $155.77M |
| TNYA Tenaya Therapeutics | $0.34 | -1.35% | -77.74% | $78.13M |
| OBIO Orchestra BioMed | $7.26 | 18.05% | 64.25% | $436.36M |
- OBIO's peers: AVTX (Avalo Therapeutics), CRBU (Caribou Biosciences), ENTA (Enanta Pharmaceuticals), EPRX (Eupraxia), IVA (Inventiva), IVVD (Invivyd), PRLD (Prelude Therapeutics), PYXS (Pyxis Oncology).
Updated 2026-11-14 00:53 UTC